Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.
Stocks Pulsate As June Inflation Undercuts Expectations: 10 Major Reactions
U.S. Consumer Price Index (CPI) inflation decelerated beyond predictions in June, impacting the investor outlook on the Federal…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Benitec Biopharma (NASDAQ:BNTC) stock increased by 99.8% to $0.4 during Monday’s regular session. As of 13:37 EST,…
Why Oric Pharmaceuticals Stock Is Shooting Higher Today
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has agreed to sell approximately 12.1 million shares of its common stock to a select group of institutional and accredited healthcare specialist investors in a
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.
ORIC Pharmaceuticals Announces $85M Private Placement Financing
Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, and Boxer Capital
Pro forma cash and investments expected to fund current
ORIC Pharmaceuticals Presents Preclinical Data On Two Programs At The 2023 American Association For Cancer Research Annual Meeting
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented two preclinical poster presentations at the 2023
4 Analysts Have This to Say About ORIC Pharmaceuticals
Within the last quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…